NASDAQ:WALD Waldencast (WALD) Stock Price, News & Analysis $1.87 0.00 (0.00%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$1.88 +0.00 (+0.27%) As of 10/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Waldencast Stock (NASDAQ:WALD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Waldencast alerts:Sign Up Key Stats Today's Range$1.82▼$1.9750-Day Range$1.49▼$2.1552-Week Range$1.48▼$4.18Volume126,284 shsAverage Volume148,886 shsMarket Capitalization$228.28 millionP/E RatioN/ADividend YieldN/APrice Target$4.97Consensus RatingModerate Buy Company Overview Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. The company is headquartered in White Plains, New York. Read More Waldencast Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScoreWALD MarketRank™: Waldencast scored higher than 29% of companies evaluated by MarketBeat, and ranked 124th out of 155 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingWaldencast has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on 5 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialWaldencast has a consensus price target of $4.97, representing about 165.9% upside from its current price of $1.87.Amount of Analyst CoverageWaldencast has only been the subject of 2 research reports in the past 90 days.Read more about Waldencast's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Waldencast are expected to decrease in the coming year, from ($0.14) to ($0.15) per share.Price to Book Value per Share RatioWaldencast has a P/B Ratio of 0.31. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Waldencast's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.70% of the float of Waldencast has been sold short.Short Interest Ratio / Days to CoverWaldencast has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Waldencast has recently increased by 47.86%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldWaldencast does not currently pay a dividend.Dividend GrowthWaldencast does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.70% of the float of Waldencast has been sold short.Short Interest Ratio / Days to CoverWaldencast has a short interest ratio ("days to cover") of 5.Change versus previous monthShort interest in Waldencast has recently increased by 47.86%, indicating that investor sentiment is decreasing significantly. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows1 people have added Waldencast to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Waldencast insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 5.90% of the stock of Waldencast is held by insiders.Percentage Held by Institutions41.97% of the stock of Waldencast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Waldencast's insider trading history. Receive WALD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Waldencast and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WALD Stock News HeadlinesWaldencast (WALD) Projected to Post Quarterly Earnings on TuesdaySeptember 28, 2025 | americanbankingnews.comWhy BeautyHealth (SKIN) Stock Is NosedivingSeptember 23, 2025 | msn.comURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash before 2025 ends. | StockEarnings (Ad)Waldencast: FDA approves Obagi saypha MagIQ injectable hyaluronic acid gelSeptember 10, 2025 | msn.comWaldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical BrandSeptember 10, 2025 | globenewswire.comWaldencast price target lowered to $2 from $2.40 at TD CowenAugust 20, 2025 | msn.comWaldencast price target lowered to $3 from $4 at Telsey AdvisoryAugust 20, 2025 | msn.comWaldencast Delays Earnings Release, Initiates Strategic Review Following Novaestiq AcquisitionAugust 19, 2025 | msn.comSee More Headlines WALD Stock Analysis - Frequently Asked Questions How have WALD shares performed this year? Waldencast's stock was trading at $4.02 at the beginning of the year. Since then, WALD stock has decreased by 53.5% and is now trading at $1.87. How do I buy shares of Waldencast? Shares of WALD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Waldencast own? Based on aggregate information from My MarketBeat watchlists, some other companies that Waldencast investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Meta Platforms (META), NVIDIA (NVDA) and Home Depot (HD). Company Calendar Today10/06/2025Next Earnings (Estimated)10/10/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry COSMETICS&TLTRS Sub-IndustryConsumer Goods Current SymbolNASDAQ:WALD CIK1840199 Webwww.waldencast.com Phone917-546-6828FaxN/AEmployees272Year FoundedN/APrice Target and Rating Average Price Target for Waldencast$4.97 High Price Target$7.50 Low Price Target$3.00 Potential Upside/Downside+165.9%Consensus RatingModerate Buy Rating Score (0-4)2.57 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$273.87 million Price / Sales0.83 Cash Flow$0.11 per share Price / Cash Flow17.00 Book Value$5.98 per share Price / Book0.31Miscellaneous Outstanding Shares122,076,000Free FloatN/AMarket Cap$228.28 million OptionableNot Optionable Beta-0.39 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:WALD) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersThis soon could be the most precious company in AmericaCurrently, a brand-new, all-American factory outside San Antonio is becoming the most significant site in the ...True Market Insiders | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Waldencast PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Waldencast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.